About Contact Us Careers
Sign In

Neurostimulation Devices Market Size & Share, by Product (Spinal Cord Stimulators, Deep Brain Stimulators, Cochlear Implants, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Percutaneous Tibial Nerve Stimulators, Transcranial Magnetic Stimulators); Application (Chronic Pain, Movement Disorders, Hearing Impairment, Epilepsy, Urinary Incontinence); End-user (Hospitals, Surgical Centers, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4239
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Companies Dominating the Neurostimulation Devices Landscape

top-features-companies
    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boston Scientific Corporation
    • Integer Holdings Corporation
    • Medtronic
    • Nevro Corp.
    • NeuroSigma, Inc.
    • NeuroPace, Inc.
    • Neuronetics
    • Synapse Biomedical Inc.
    • Soterix Medical, Inc.
Browse Key Market Insights with Data Illustration:

In the News

  • Nevro Corp., a global medical device company, today announced that its Senza system has been successfully approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy (PDN). With the approval, the company will immediately begin its commercial production in the United States.

  • NeuroSigma, Inc., a bioelectronic medical device company, today announced that the company received an equity investment of USD 5 million from KT Corporation, an international digital telecommunication company. With the investment, the company will support the commercialization and development of Monarch eTNS Systems and accelerate the business growth trajectory of NeuroSigma.

 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4239
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of chronic pain and increasing neurological disorders are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of ~12% over the forecast period, i.e., 2023-2035.

High cost of neurostimulation devices and dearth of skilled professionals are estimated to hinder market growth.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Boston Scientific Corporation, Integer Holdings Corporation, Medtronic, Nevro Corp., NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Synapse Biomedical Inc., Soterix Medical, Inc. and Abbott Laboratories

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user and by region.

The hospitals segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying